Trial intelligence / Profile preview

Mannitol timing for brain relaxation in craniotomy

TCTR20250224001Phase 2Completed

Sponsor
N/A
Start
Aug 2023
Modality
Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 2 trial of Bronchitol in None (2 arms), sponsored by N/A. Primary endpoint: Brain relaxation at craniotomy. Started Aug 2023; status: completed.

02

Drugs

Bronchitol

Beyond the preview

Go deeper on TCTR20250224001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250224001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call